ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
F2G Receives Second FDA Breakthrough Therapy Designation for Olorofim americanpharmaceuticalreview
October 29, 2020F2G announced the US Food and Drug Administration (FDA) has granted an additional Breakthrough Therapy Designation to its lead first-in-class candidate, olorofim, for the indication of “Treatment of Central Nervous System (CNS) coccidioidomycosis ... -
F2G Receives Orphan Drug Designation for Olorofim americanpharmaceuticalreview
March 10, 2020F2G announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead first-in-class candidate, olorofim (formerly F901318) for treatment of invasive aspergillosis ...
Pharma Sources Insight January 2025
